Targeting of the COX-2/PGE2 axis enhances the antitumor activity of T7 peptide in vitro and in vivo

T7 peptide is considered as an antiangiogenic polypeptide. The presents study aimed to further detect the antiangiogenic mechanisms of T7 peptide and determine whether combining T7 peptide and meloxicam (COX-2/PGE2 specific inhibitor) could offer a better therapy to combat hepatocellular carcinoma (...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jianrong, Zhong, Jingtao, Zhou, Mi, Zhou, Yinghong, Xiu, Peng, Liu, Feng, Wang, Fuhai, Li, Zelun, Tang, Yuntian, Chen, Yuanyuan, Yao, Siyang, Huang, Tao, Liu, Tianqi, Dong, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812588/
https://www.ncbi.nlm.nih.gov/pubmed/33928829
http://dx.doi.org/10.1080/10717544.2021.1914776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812588/
https://www.ncbi.nlm.nih.gov/pubmed/33928829
http://dx.doi.org/10.1080/10717544.2021.1914776

Ejemplares similares